Close Menu

NEW YORK – Bio-Rad Laboratories said after the close of the market on Thursday that its fourth quarter revenues rose approximately 27 percent year over year.

Bio-Rad also announced it received Emergency Use Authorization from the US Food and Drug Administration for a combined COVID-19, influenza A, and influenza B multiplex syndromic RT-PCR test.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Apr
29
Sponsored by
Co-Diagnostics

Join Dr. Heather Fehling, Chief Scientific Officer at Clinical Reference Labs (CRL), as she provides some insights regarding the future applications of PCR testing.

May
18
Sponsored by
Bio-Rad

This webinar will present the details of a COVID-19 saliva screening program that has been implemented at more than 90 different colleges, universities, private schools, and nursing homes across New York state.